@drnilabja.bsky.social
Reposted
Israel researchers studied two antibodies, TAU-1109 and TAU-2310, from early COVID-19 patients and found they neutralize every variant, including Omicron, by latching onto hidden spike regions and forcing the virus to shed its entry protein.
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Monoclonal Antibodies from COVID-19 Convalescent Patients Target Cryptic Epitopes for Universal SARS-CoV-2 Neutralization
The COVID-19 pandemic, which has resulted in over seven million global fatalities, poses a substantial threat to public health and precipitated a global economic crisis. Emerging variants of concern (...
www.biorxiv.org
August 20, 2025 at 11:31 PM
Israel researchers studied two antibodies, TAU-1109 and TAU-2310, from early COVID-19 patients and found they neutralize every variant, including Omicron, by latching onto hidden spike regions and forcing the virus to shed its entry protein.
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...